On 29-30th October Vision2020, in collaboration with MedCity and Research Media, will be hosting Health Tech 2020 at London City Hall.
This event will provide you with opportunities for networking and matchmaking and will help you to form winning project consortia to target the €2 billion of funding earmarked for Health Tech activities from upcoming EU "Horizon 2020" calls.Click here to book your Delegate Pass
Abdul Rahim is a founder and director of Vision2020: The Horizon Network. His key skills are developing and maintaining successful partnerships and joint ventures. He is an expert in public funding and has secured several € millions for organisations and institutions. He has run several European funded projects to help smaller businesses secure contracts from the public sector and is a regular speaker at events.
Abdul has significant links with UK and European Universities and focuses on connecting business to research institutions. He was on the board of London Metropolitan University from its formation to March 2010. He was Vice Chairman and Chair of its Finance and Human Resources Committee. Prior to that he was on the board of University of North London and was on the joint board during the merger with London Guildhall University to form London Metropolitan University. He is currently an Advisory Board Member, Faculty of Business and Management at Regent’s University.
Abdul holds a Masters in Business Administration (MBA), is a Fellow of The Royal Society of Arts & Manufacturing, and a Member of Institute of Economic Development.
Joanne Hackett is Director of Commercial Development for UCLPartners. In this role she is creating a portfolio of external investments and strategic alliances which advances technology and product strategies. Her role creates a sustainable, competitive advantage for UCLPartners; and contributes to attainment of research, development and commercialisation goals.
Joanne has been actively involved in clinical research for over 15 years in Canada, America, Germany, Sweden and the UK. She is an accomplished entrepreneur, scientist and strategist with experience in the execution and management of complex business transactions. Broad business development experience includes the negotiation, execution and management of hundreds of transactions with pharma, biotech, academia and non-profits including co-development/co-promotion, in/out licensing, collaborative R&D, and consortia.
Joanne has a multi-disciplinary educational background in regenerative medicine, tissue engineering, stem cell biology and polymer chemistry. She also holds a diploma in university teaching and a professional certificate in project management.
Liesa Siedentopp is Project Advisor for the ‘SME instrument’ innovation programme in the Executive Agency for Small and Medium-Sized Enterprise (EASME).
From 2013-2014 she has been preparing for the European Commissions’ Directorate-General ‘Research and Innovation’ and Directorate-General ‘Enterprise and Industry’ the legal implementation of the European funding programmes Horizon 2020 and COSME. Both programs started to be operational as from 2014 focussing on Innovation in Small and Medium-Sized Enterprises in Europe.
Previously, she served several years as political advisor to a German Member of the European Parliament in the Transport and Tourism Committee working on questions of sustainable mobility solutions and transport networks and volunteered for the ‘Positive Economy Network’ of sustainable companies in Belgium. During the German presidency of the European Union in 2007 Liesa has been active in the diplomatic foreign relations area acting as Vice Head of Protocol of the German Representation to the EU, among others being responsible for managing high-level European summits and Ministerial Councils.
She holds a Master’s degree in European Studies from Leibniz University of Hannover and a Bachelor degree in Cultural Studies from Viadrina University of Frankfurt/Oder. During her studies she obtained a scholarship from the Erasmus programme to follow courses in Louvain-la-Neuve University/Belgium and Warsaw University/Poland.
Liesa speaks German, English, French, Spanish and Dutch.
Michael Browne is Head of the European Research & Innovation Office (ERIO) at University College London and is responsible for the direction and management of ERIO, which involves the oversight and delivery of pre-proposal, pre-award, proposal writing and project management teams. Michael is the designated institutional expert on European Commission funded research and innovation with 13 years’ experience in this field, and now with a specific focus on Horizon 2020 and Innovation Management.
He is University College London's Legal Entity. Authorised Representative (LEAR) on all European Commission research and innovation contracts (in excess of 750 projects totalling more than €420 million). UCL was recently ranked, by research professional, as the top performing university in Europe under the first year of Horizon 2020.
In addition, Michael is Chair of the Vision2020: The Horizon Network Strategy Board, EU national expert & regional rapporteur for Mobilizing Institutional Reform in Research & Innovation Systems (MIRRIS), an EU Regional Expert on Horizon 2020, a Steering Group Member of the League of European Research Universities, and a Universities UK Sounding Board Member for Horizon 2020. Michael has published a number of papers and articles related to the European Research Area, EU funded research and innovation and the European Research Council. Michael was the prime author of the League of European Research Universities position paper on Horizon 2020 entitled: “Clear Choices for Europe: smart investment in research and innovation”. Michael is currently working with the UK Government’s Department for Business Innovation and Skills (BIS) to produce a series of UK-based case studies of SMEs who have been able to successfully innovate by accessing and leveraging funding from Horizon 2020. Finally, Michael currently sits on the “Universities UK” Horizon 2020 Innovation Strategy Committee.
Michael has overseen the award and successful delivery of more than 1,000 EU funded projects. Michael sits on various panels at national and international level, and is an expert advisor to the EC on innovation, institutional reform and impact.
Sarah Haywood became Chief Operating Officer of MedCity in October 2014, after fulfilling the role in an acting capacity since its launch in April 2014 alongside her position as Head of Life Sciences at London & Partners.
She is a graduate of the NHS Management Training Scheme in Wales and started her career in the NHS, working in a number of NHS Trusts, including Great Ormond Street NHS Foundation Trust, before joining Novartis Pharmaceuticals Research as the Head of Operations for a neuroscience drug discovery unit, located on the UCL campus.
From there, Sarah joined the civil service and undertook a number of roles as a member of the Senior Civil Service, including leading the DTI (now BIS) Bioscience Unit before it became part of the Office for Life Sciences. Her last role in BIS was leading the design and legislation for the extension of the right to request flexible working and the shared parental leave system. In January 2014 she joined London & Partners where she worked with Dr Eliot Forster to establish MedCity.
Sarah has a degree in Biology from the University of Oxford, a post graduate diploma in management and an MA in human resources management; she is a chartered fellow of the Chartered Management Institute.
David Gann is responsible for shaping the vision, strategy and innovation agenda for Imperial College, and the development of its new London campus at White City. He is a member of the College’s Executive Board, responsible for new ventures such as ThinkSpace, increasing and diversifying income. In 2015 he led a review of Imperial’s Technology Transfer, Translation and collaboration activities.
He holds the Chair in Innovation and Technology Management at Imperial College Business School and Department of Civil & Environmental Engineering, Imperial College London. He is a Chartered Civil Engineer with a PhD in Industrial Economics.
David’s research focuses on innovation in the digital economy, new business models and innovation strategy in technology firms. David founded Imperial’s Innovation and Entrepreneurship Department.
David is Chairman of the Smart London Board, reporting to Boris Johnson, Mayor of London. He is the Higher Education representative on the London Enterprise Panel and a member of the London Enterprise Panel’s Digital, Creative, Science & Technology Group and Economic Development Advisory Group. He is a member of the Smart Cities All-Party Parliamentary Group and the Greater London Authority’s Investment Infrastructure Plan Advisory Group.
David received the 2014 Tjalling C. Koopmans Asset Award for extraordinary contributions to the economic sciences. He was appointed Commander of the Order of the British Empire (CBE) in the 2010 Queen's Birthday Honours for services to engineering.
Jim Smith is Deputy Chief Executive and Chief of Strategy at the Medical Research Council (MRC) as well as Director of Research at the Francis Crick Institute. Jim was previously Director of the MRC’s National Institute for Medical Research (NIMR), a post he took up in 2009. He was previously Professor of Developmental Biology and Director of the Gurdon Institute at Cambridge University.
Jim studies mesoderm formation in vertebrate embryos and in human and mouse embryonic stem cells. His work will help drive stem cell differentiation along the appropriate developmental pathways. He has published about 200 peer-reviewed papers. Jim is a Fellow of the Royal Society and of the Academy of Medical Sciences and has won numerous awards including the European Molecular Biology Organisation (EMBO) medal in 1994 and the Waddington Medal of the British Society for Developmental Biology (BSDB) in 2013.
The main focus of Professor Reza Razavi’s research is imaging and biomedical engineering related to the cardiovascular disease. One area of focus is cardiac MRI particularly in relation to congenital heart disease, electrophysiology and heart failure, image guided intervention, XMR (X-ray and MRI) guided cardiac catheterisation and methodological advances to move to faster 3-Dimensional cardiac imaging. His group was the first to perform MRI guided cardiac catheterisation in patients and more recently the first group to carry out entirely MR guided cardiovascular interventions.
In congenital heart disease he has developed techniques for three-dimensional imaging as well as physiological assessment using flow measurements. Using MR guided cardiac catheterisation his group has developed new techniques of measuring pulmonary vascular resistance and compliance. In the area of cardiac arrhythmias and heart failure and devices new biomarkers for therapy guidance and therapy assessment as well as multi-modal techniques for image guided intervention have been developed. Methodological developments in this area include advances in MR acquisition and reconstruction and processing as well as techniques for multi-modal imaging integration. More recent research areas include the use of biophysical computational models to better understand pathological mechanisms and help guide treatments and molecular imaging using newly developed molecular imaging markers both in animal and human models.
Ian Owen joined Fujitsu Services in 2015 as Head of Health and Education within its Public Sector market facing unit following a career of 15 years providing transformational Business and ICT solutions to a range of clients across the public sector on behalf of companies such as Oracle, SAP, Vodafone, CGI and Serco.
He is a Chartered Public Finance Accountant who, prior to joining the private sector, held a number of senior posts in local government finance in Lancashire before joining the Civil Service as a Government Accountant with the DWP. After Financial and Systems Management roles within the DWP Ian moved more into ICT consultancy and then business development where he has worked extensively with Local and Central Government, Health and Higher Education/Research.
Ian has been an examiner for his accounting institute, CIPFA, and has served on its national council as well as several committees and advisory panels.
Stijn Delauré is Head of the International Research unit at KU Leuven (University of Leuven, Belgium) and is responsible for the international and European research policy of the university. He is one of two heads of the KU Leuven EU research support team, which successfully secured over 640 Framework Program projects for KU Leuven since 2007, worth over 315 million euro.
KU Leuven is second European university in Reuters’ 2015 ranking of the world’s most innovative universities and 6th university in the Horizon 2020 ranking. Stijn is Chair of the EU officers Community of LERU (League of European Research Universities), which focuses on lobbying in Brussels on Horizon 2020 as well as sharing practices amongst its 21 member universities. He is representing LERU in the European Commission’s Advisory Group for the Marie Sklodowska Curie Actions in Horizon 2020 and different Horizon 2020 stakeholder fora. Stijn holds a PhD in Biotechnology, worked at the Technology Discovery department of Bayer CropScience, and was a researcher in the Microbial and Molecular Systems department of KU Leuven, before he joined the Research Coordination Office of KU Leuven. He is a member of Vision2020, EARMA, Coimbra Group’s Research Support Officers, and management committee member of the COST action BESTPRAC
Robin Shattock is a professor of Mucosal Infection and Immunity at Imperial College, London. The main focus of his research is the investigation of the mechanisms of mucosal HIV transmission and development of novel preventative strategies. Prof Shattock has secured funding from the Wellcome Trust, NIH, European Commission, and the Bill and Melinda Gates Foundation.
Prof. Shattock Chairs the Research and Advisory Steering Committee of the International Partnership for Microbicides and the WHO AIDS Vaccine Advisory committee and is a member of the Scientific Advisory boards of Global HIV Vaccine Enterprise Scientific Committee (GHVE) and the International AIDS Vaccine Initiative (IAVI).
Mike is a medicinal chemist with 18 years postdoctoral experience in research, project management, business development and consulting. Mike helped develop the biotech cluster in the Northwest of England (Bionow) and became a founder of the Northwest Genetics Knowledge Park. He has extensive experience with internationalising biotech companies and has helped a number of biotechs win business and develop partnerships overseas.
Between 2005 and 2008, he was with UKTI in Boston USA as the British Government’s North American Advisor on the life science industries. More recently he was Bio Nano Consulting's Business Development Director, where he also consulted on nanotechnology in healthcare for the UK Knowledge Transfer Network. Mike has been a co-ordinator on 2 EU funded projects and has lead on 5 successful proposals for European funding, securing over €8m.
Development and Research Directors
Heads of European Research and Innovation
EU Funding Specialists
CEOs of Small to Medium Enterprises
The Queens Walk, London SE1 2AA
London & Partners
6th Floor, 2 More London Riverside, London SE1 2RR
London Bridge - (7 minute walk)
Tower Hill - (13 minute walk)
|Branding at the event||x||x||x|
|Delgate passes||x (8)||x (5)||x (3)|
|Invitation to the second day||x||x||x|
|Inclusion of printed marketing collateral or other brand promotional items for delegates||x||x||x|
|Vision 2020 Membership||x||x||x|
|Advertising in International Innovation||x||x||x|
|Advertising on www.internationalinnovation.com||x||x||x|
|Company profile in International Innovation||x||x|
|Speaking opportunity on Day 1||x|
|Pre-lunch Speaking opportunity in Day 1 opening session||x|
|Hosts of one of the lunch areas||x|
|Exclusive hosts of the Registration and post-event dinner||x|
|Brief speaking opportunity at the post-event dinner||x|
|Receipt of the delegate list (does not include email addresses)||x|
|Acknowledgement of your sponsorship on both days||x|
|Speaking opportunity on Day 2||x|
|Introduction of the final key note speaker||x|
|Site take-over on www.internationalinnovation.com||x|
|Branding on e-newsletter to the International Innovation database||x|
To find out more please get in touch
MedCity is a collaboration between the Mayor of London and the Capital’s three Academic Health Science Centres - Imperial College Academic Health Science Centre, King’s Health Partners and UCLPartners.
Vision2020: The Horizon Network is a global networking platform that helps organisations to connect and collaborate through the €80 billion Horizon 2020 research and innovation funding programme. Vision2020 specialises in networking and matchmaking activities, and helps potential applicants form winning consortia by identifying common interests between research organisations, companies and universities within different sectors. It finds opportunities and encourages collaboration on a global level, driving effective participation in the Horizon 2020 programme. Launched in April 2013, Vision2020 has over 200 research intensive members from 35 countries.
Research Media is a communications agency that provides integrated creative services for the research sector. As specialist suppliers of highly effective online and offline dissemination services and channels, Research Media offers a broad range of skills across editorial, design and web.
Research Media’s specialism lies in bringing clarity from complexity; communicating across a variety of engaging and impactful platforms. Whether that be an infographic, animation, microsite or a bespoke publication, we are confidently able to exceed our clients’ expectations in the most innovative and compelling way.